HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael B A Oldstone Selected Research

Viral RNA

6/2012Toll-like receptor 7 is required for effective adaptive immune responses that prevent persistent virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael B A Oldstone Research Topics

Disease

45Infections
02/2024 - 07/2002
32Virus Diseases (Viral Diseases)
11/2021 - 07/2002
9Cytokine Release Syndrome
06/2014 - 07/2011
7Lassa Fever (Fever, Lassa)
11/2022 - 11/2003
7Scrapie
08/2012 - 05/2002
6Persistent Infection
01/2014 - 02/2005
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2017 - 11/2004
5Human Influenza (Influenza)
01/2014 - 10/2011
4Vesicular Stomatitis
11/2022 - 05/2005
4Autoimmune Diseases (Autoimmune Disease)
06/2014 - 12/2003
4Inflammation (Inflammations)
06/2014 - 09/2005
4Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2013 - 06/2005
4Arenaviridae Infections
10/2011 - 11/2003
3Muscular Dystrophies (Muscular Dystrophy)
01/2010 - 06/2004
2Neoplasms (Cancer)
12/2019 - 10/2002
2Lymphopenia (Lymphocytopenia)
10/2015 - 02/2010
2Lung Injury
03/2014 - 07/2011
2Amyloid Plaque
09/2013 - 03/2011
2Heart Diseases (Heart Disease)
09/2013 - 07/2006
2Disease Progression
04/2013 - 04/2003
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2008 - 11/2005
1COVID-19
11/2021
1Chickenpox
01/2019
1Fever (Fevers)
10/2016
1Lung Diseases (Lung Disease)
06/2014
1Respiratory Tract Diseases (Respiratory Tract Disease)
06/2014
1Communicable Diseases (Infectious Diseases)
01/2014
1Sporadic Creutzfeldt-Jakob Disease
09/2013
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
09/2013
1Lymphocytic Choriomeningitis
03/2013
1Edema (Dropsy)
01/2013
1Hypopigmentation (Hypomelanosis)
08/2012
1Immune System Diseases (Immune Disorders)
07/2011
1Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
03/2011
1Cognitive Dysfunction
03/2011
1Walker-Warburg Syndrome
01/2010
1Hyperglycemia
11/2009
1Opportunistic Infections (Opportunistic Infection)
10/2008

Drug/Important Bio-Agent (IBA)

18Antiviral Agents (Antivirals)IBA
01/2022 - 07/2002
11AntigensIBA
11/2022 - 10/2002
11CytokinesIBA
01/2015 - 04/2003
9Dystroglycans (Dystroglycan)IBA
10/2011 - 11/2003
8Prion ProteinsIBA
09/2013 - 03/2003
7Glycoproteins (Glycoprotein)IBA
01/2019 - 07/2002
7Proteins (Proteins, Gene)FDA Link
02/2011 - 02/2003
6sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2021 - 10/2011
6Interferon Type IIBA
01/2016 - 12/2004
6Interleukin-10 (Interleukin 10)IBA
07/2015 - 03/2008
6Sphingosine-1-Phosphate ReceptorsIBA
06/2014 - 02/2010
5VaccinesIBA
11/2022 - 03/2008
5LigandsIBA
12/2019 - 12/2003
5ChemokinesIBA
01/2015 - 12/2003
5SphingosineIBA
01/2013 - 09/2008
4InterferonsIBA
01/2017 - 04/2013
4PrionsIBA
09/2013 - 07/2006
3Neutralizing AntibodiesIBA
06/2014 - 08/2004
3Amyloid (Amyloid Fibrils)IBA
09/2013 - 07/2006
3NucleoproteinsIBA
08/2013 - 09/2005
3Phosphates (Orthophosphate)IBA
03/2013 - 09/2008
3Toll-Like Receptors (Toll-Like Receptor)IBA
06/2007 - 05/2004
3EpitopesIBA
01/2006 - 02/2003
2Interferon-gamma (Interferon, gamma)IBA
06/2014 - 03/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2014 - 03/2006
2Peptide Hydrolases (Proteases)FDA Link
08/2012 - 03/2011
2Histocompatibility Antigens Class IIIBA
05/2012 - 06/2004
2Laminin (Merosin)IBA
10/2011 - 01/2010
2Insulin (Novolin)FDA Link
11/2009 - 09/2005
2InterleukinsIBA
03/2008 - 11/2006
2Amino AcidsFDA Link
08/2007 - 07/2002
2Cell Surface ReceptorsIBA
11/2005 - 05/2005
2Double-Stranded RNA (RNA, Double Stranded)IBA
12/2004 - 05/2004
2AutoantigensIBA
11/2004 - 04/2003
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2024
1Interleukin-27 (Interleukin 27)IBA
01/2022
1Immunoglobulin IsotypesIBA
01/2022
1LysophospholipidsIBA
11/2021
1Indicators and Reagents (Reagents)IBA
11/2021
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2020
1EnzymesIBA
01/2019
1ImmunosorbentsIBA
01/2019
12- (4- (5- (3,4- diethoxyphenyl)- 1,2,4- oxadiazol- 3- yl)- 2,3- dihydro- 1H- inden- 1- yl amino)ethanolIBA
01/2017
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2015
1Interferon-alpha (Interferon Alfa)IBA
05/2015
1Interferon-betaIBA
05/2015
1RNA (Ribonucleic Acid)IBA
01/2015
1Oseltamivir (Tamiflu)FDA Link
03/2014
1SolutionsIBA
03/2014
1Formaldehyde (Formol)FDA Link
09/2013
1MicroRNAs (MicroRNA)IBA
08/2013
1CopperIBA
08/2012
1Interleukin-2 (IL2)IBA
08/2012
1Viral RNAIBA
06/2012
1Toll-Like Receptor 7IBA
06/2012
1TB-403IBA
10/2011
1Fingolimod Hydrochloride (FTY720)FDA Link
02/2010
1AUY 954IBA
02/2010
1Mannose (D-Mannose)IBA
01/2010
1flt3 ligand protein (flt3 ligand)IBA
12/2008
1Immunoglobulin D (IgD)IBA
12/2008

Therapy/Procedure

10Therapeutics
06/2014 - 02/2005